Cite
MLA Citation
Keke Nie et al.. “Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer.” Lung cancer, vol. 121, 2018, pp. 5–11. http://access.bl.uk/ark:/81055/vdc_100064813611.0x000042